Citius Oncology Inc.

1.27
0.07 (5.83%)
At close: Jan 30, 2025, 3:59 PM
1.26
-0.79%
After-hours Jan 30, 2025, 04:00 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY24 FY23 FY22
Net Income -21.15M -12.70M -5.43M
Depreciation & Amortization n/a n/a n/a
Stock-Based Compensation 7.50M 1.97M n/a
Other Working Capital 10.78M 8.61M 4.74M
Other Non-Cash Items n/a n/a n/a
Deferred Income Tax 576.00K 576.00K 576.00K
Change in Working Capital 13.20M 10.16M 4.86M
Operating Cash Flow 126.35K n/a n/a
Capital Expenditures -5.00M n/a n/a
Acquisitions n/a n/a n/a
Purchase of Investments n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a
Other Investing Acitivies n/a n/a n/a
Investing Cash Flow -5.00M n/a n/a
Debt Repayment 3.80M n/a n/a
Common Stock Repurchased n/a n/a n/a
Dividend Paid n/a n/a n/a
Other Financial Acitivies 1.07M n/a n/a
Financial Cash Flow 4.87M n/a n/a
Net Cash Flow 112.00 n/a n/a
Free Cash Flow -4.87M n/a n/a